Piramal Pharma (NSE:PPLPHARMA) Operating Cash Flow per Share : ₹0.00 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Operating Cash Flow per Share?

Piramal Pharma's operating cash flow per share for the three months ended in Mar. 2024 was ₹0.00. Piramal Pharma's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Piramal Pharma was 97.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 202.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Piramal Pharma's Operating Cash Flow per Share or its related term are showing as below:

NSE:PPLPHARMA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 202.5 Med: 202.5 Max: 202.5
Current: 202.5

During the past 4 years, Piramal Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 202.50% per year. The lowest was 202.50% per year. And the median was 202.50% per year.

NSE:PPLPHARMA's 3-Year OCF Growth Rate is ranked better than
99.63% of 803 companies
in the Drug Manufacturers industry
Industry Median: 7 vs NSE:PPLPHARMA: 202.50

Piramal Pharma Operating Cash Flow per Share Historical Data

The historical data trend for Piramal Pharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Operating Cash Flow per Share Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Operating Cash Flow per Share

0.29

6.30

4.00

7.89

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Piramal Pharma's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piramal Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's Price-to-Operating-Cash-Flow falls into.

Piramal Pharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Piramal Pharma's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )	=	Cash Flow from Operations (A: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2024 )
	=	10045.4	/	1272.857
	=	7.89

Piramal Pharma's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	0	/	1298.247
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

Piramal Pharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines